GMED vs BAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jan 27, 2026
GMED
BAX
Investment Advisor Scores
BAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GMED | BAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 21.2766 | 8.4602 | BAX |
| PEG Ratio | 1.7253 | 36.7693 | GMED |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 22.9% | 5.0% | GMED |
| Earnings Growth | 131.6% | 237.9% | BAX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.9/100 | 57.3/100 | GMED |
| Profit Margin | 15.3% | -3.1% | GMED |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | GMED |